Naptumomab Estafenatox
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Naptumomab Estafenatox, covering 2015-07-22 to 2025-11-28. Get the full timeline:
Most recent: Clinical Trial Update: Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer. [Phase 1]